Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emir Berberovic
Institution:
Parkinson-Klinik Ortenau
Observed institution:
Parkinson-Klinik Ortenau
ORCID:
0009-0008-3735-8168
Observed ORCID:
0009-0008-3735-8168
OpenAlex ID:
A5104631677
Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendations
2025
·
Thomas Koeglsperger
, Emir Berberovic
, et al.
·
Journal of Neural Transmission
·
28
Cerebellar, Not Nigrostriatal Degeneration Impairs Dexterity in Multiple System Atrophy
2023
·
Alexander Rau
, Jonas A. Hosp
, et al.
·
Movement Disorders
·
17
Therapy with botulinum neurotoxin for Parkinson’s disease
2024
·
Wolfgang H. Jost
, Emir Berberovic
·
Journal of Neural Transmission
·
2
Pre- and post-void residual volume in Parkinson’s disease patients with urinary urgency, incontinence or nocturia
2026
·
Edina Vitaszil
, Emir Berberovic
, et al.
·
Neurologia i Neurochirurgia Polska
·
1
PDF
Lower urinary tract symptoms in Parkinson’s disease: A review
2025
·
Edina Vitaszil
, Emir Berberovic
, et al.
·
Bladder
·
1
Striatal Toe: Too Harmless to Treat?
2025
·
Wolfgang H. Jost
, Emir Berberovic
·
Toxins
·
1
Idiopathic Cervical Dystonia and Cervical Dystonia in Parkinson’s Disease -A Common Pathophysiology, Clinical Pattern and Treatment?
2026
·
Marita F Thiel
, Jaroslaw Slawek
, et al.
·
Journal of Neurology and Experimental Neural Science
PDF
Einsatzmöglichkeiten des Botulinum- Neurotoxins bei der Parkinson-Krankheit
2024
·
Wolfgang H. Jost
, Emir Berberovic
·
Nervenheilkunde
PDF
Therapieansätze für das fortgeschrittene idiopathische Parkinson-Syndrom: Kontinuierliche dopaminerge Stimulationsverfahren im Überblick
2023
·
Emir Berberovic
, Wolfgang H. Jost
·
DNP – Die Neurologie & Psychiatrie
Show more works
View as search
Works count:
9
Citation count:
50
H-index:
2
I10-index:
2
Year
Topic
Type
